“Our providers and nursing staff at Piedmont Transplant had known that a collaborative approach with the Walgreens specialty pharmacy was improving access to expensive but highly curative Hepatitis C medications, but we had never examined the data to quantify the benefits,” Lance L. Stein, MD, a hepatologist at Piedmont Transplant Institute in Atlanta, said in a prepared statement. “By combining our patient level data we can now quantify this collaboration’s benefits in expediting access to medications, lowering costs, and still achieve the high rates of cure seen in DAA clinical studies.”
Noting that the Piedmont patients are sicker than most patients with hepatitis C, including transplant patients, Markes-Wilson said to “get such a high SVR rates with sick patients is really a testament to our work and the collaboration.”
A big part of what the Walgreens specialty pharmacy team does is patient education and checking for drug interactions and adherence to protocols, she noted.
“We communicate regularly to ensure that patients are adherent to their care plans and address any side effects, while keeping our providers in the loop,” Markes-Wilson said. “The patient may only see his physician once a month, but we have multiple touch points throughout that time.”